Literature DB >> 29328926

DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia.

Kai-Hei Tse1, Aifang Cheng2, Fulin Ma2, Karl Herrup2.   

Abstract

INTRODUCTION: In looking for novel non-amyloid-based etiologies for Alzheimer's disease, we explore the hypothesis that age-related myelin loss is an attractive explanation for age-associated cognitive decline and dementia.
METHODS: We performed a meta-analysis of data in the National Alzheimer's Coordinating Center database accompanied by quantitative histopathology of myelin and oligodendrocytes (OLs) in frontal cortices of 24 clinically characterized individuals. Pathological findings were further validated in an Alzheimer's disease mouse model and in culture.
RESULTS: Myelin lesions increased with cognitive impairment in an amyloid-independent fashion with signs of degeneration appearing before neuronal loss. Myelinating OLs in the gray matter showed greater vulnerability than those in white matter, and the degenerative changes correlated with evidence of DNA damage. Similar results were found in myelinating OL cultures where DNA damage caused aberrant OL cell cycle re-entry and death. DISCUSSION: We present the first comprehensive analysis of the cell biology of early myelin loss in sporadic Alzheimer's disease.
Copyright © 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid plaques; DNA damage; Dementia; Myelin; Oligodendrocyte

Mesh:

Year:  2018        PMID: 29328926      PMCID: PMC5938117          DOI: 10.1016/j.jalz.2017.11.010

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  87 in total

1.  Change of conduction velocity by regional myelination yields constant latency irrespective of distance between thalamus and cortex.

Authors:  Mahmoud Salami; Chiaki Itami; Tadaharu Tsumoto; Fumitaka Kimura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  Differential aging of cerebral white matter in middle-aged and older adults: A seven-year follow-up.

Authors:  Andrew R Bender; Manuel C Völkle; Naftali Raz
Journal:  Neuroimage       Date:  2015-10-19       Impact factor: 6.556

Review 3.  Myelination and the trophic support of long axons.

Authors:  Klaus-Armin Nave
Journal:  Nat Rev Neurosci       Date:  2010-03-10       Impact factor: 34.870

Review 4.  Quantitative systematic review of the effects of non-pharmacological interventions on reducing apathy in persons with dementia.

Authors:  Emilie Dykstra Goris; Katherine N Ansel; Debra L Schutte
Journal:  J Adv Nurs       Date:  2016-06-23       Impact factor: 3.187

5.  Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination.

Authors:  Ben Emery; Dritan Agalliu; John D Cahoy; Trent A Watkins; Jason C Dugas; Sara B Mulinyawe; Adilijan Ibrahim; Keith L Ligon; David H Rowitch; Ben A Barres
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

6.  Cyclin-dependent kinase 5 mediates adult OPC maturation and myelin repair through modulation of Akt and GsK-3β signaling.

Authors:  FuCheng Luo; Kathryn Burke; Christopher Kantor; Robert H Miller; Yan Yang
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

7.  Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings.

Authors:  W O Tobin; B F Popescu; V Lowe; I Pirko; J E Parisi; K Kantarci; J A Fields; M B Bruns; B F Boeve; C F Lucchinetti
Journal:  Mult Scler       Date:  2015-10-07       Impact factor: 6.312

8.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

9.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

10.  Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation.

Authors:  Jeffrey A Blair; Chunyu Wang; Damarys Hernandez; Sandra L Siedlak; Mark S Rodgers; Rojan K Achar; Lara M Fahmy; Sandy L Torres; Robert B Petersen; Xiongwei Zhu; Gemma Casadesus; Hyoung-Gon Lee
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

View more
  15 in total

Review 1.  Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging.

Authors:  Farzaneh A Sorond; Shawn Whitehead; Ken Arai; Douglas Arnold; S Thomas Carmichael; Charles De Carli; Marco Duering; Myriam Fornage; Rafael E Flores-Obando; Jonathan Graff-Radford; Edith Hamel; David C Hess; Massafumi Ihara; Majken K Jensen; Hugh S Markus; Axel Montagne; Gary Rosenberg; Andy Y Shih; Eric E Smith; Alex Thiel; Kai Hei Tse; Donna Wilcock; Frank Barone
Journal:  Geroscience       Date:  2019-12-06       Impact factor: 7.713

2.  DNA Repair Inhibition Leads to Active Export of Repetitive Sequences to the Cytoplasm Triggering an Inflammatory Response.

Authors:  Xuan Song; Jacqueline T M Aw; Fulin Ma; Ming Fung Cheung; Danny Leung; Karl Herrup
Journal:  J Neurosci       Date:  2021-09-30       Impact factor: 6.167

3.  Apolipoprotein E ε4 Mediates Myelin Breakdown by Targeting Oligodendrocytes in Sporadic Alzheimer Disease.

Authors:  Gerald Wai-Yeung Cheng; Kingston King-Shi Mok; Sunny Hoi-Sang Yeung; Julia Kofler; Karl Herrup; Kai-Hei Tse
Journal:  J Neuropathol Exp Neurol       Date:  2022-08-16       Impact factor: 3.148

4.  Greater Diffusion Restriction in White Matter in Preclinical Alzheimer Disease.

Authors:  Andreana Benitez; Jens H Jensen; Kathryn Thorn; Siddhartha Dhiman; Stephanie Fountain-Zaragoza; William J Rieter; Maria Vittoria Spampinato; Eric D Hamlett; Paul J Nietert; Maria de Fatima Falangola; Joseph A Helpern
Journal:  Ann Neurol       Date:  2022-03-30       Impact factor: 11.274

5.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

6.  DNA Double-Strand Break Accumulation in Alzheimer's Disease: Evidence from Experimental Models and Postmortem Human Brains.

Authors:  Nidheesh Thadathil; David F Delotterie; Jianfeng Xiao; Roderick Hori; Michael P McDonald; Mohammad Moshahid Khan
Journal:  Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.590

Review 7.  Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders.

Authors:  Jan Spaas; Lieve van Veggel; Melissa Schepers; Assia Tiane; Jack van Horssen; David M Wilson; Pablo R Moya; Elisabeth Piccart; Niels Hellings; Bert O Eijnde; Wim Derave; Rudy Schreiber; Tim Vanmierlo
Journal:  Cell Mol Life Sci       Date:  2021-03-10       Impact factor: 9.261

Review 8.  Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair.

Authors:  Emily Leung; Lili-Naz Hazrati
Journal:  Brain Commun       Date:  2021-05-27

Review 9.  Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set.

Authors:  Lilah Besser; Walter Kukull; David S Knopman; Helena Chui; Douglas Galasko; Sandra Weintraub; Gregory Jicha; Cynthia Carlsson; Jeffrey Burns; Joseph Quinn; Robert A Sweet; Katya Rascovsky; Merilee Teylan; Duane Beekly; George Thomas; Mark Bollenbeck; Sarah Monsell; Charles Mock; Xiao Hua Zhou; Nicole Thomas; Elizabeth Robichaud; Margaret Dean; Janene Hubbard; Mary Jacka; Kristen Schwabe-Fry; Joylee Wu; Creighton Phelps; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

Review 10.  White Matter and Neuroprotection in Alzheimer's Dementia.

Authors:  Luca Lorenzini; Mercedes Fernandez; Vito Antonio Baldassarro; Andrea Bighinati; Alessandro Giuliani; Laura Calzà; Luciana Giardino
Journal:  Molecules       Date:  2020-01-23       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.